Precipio (PRPO)

• Market cap: $54.3M
• 1 day: -1.55%
• 5 days: 7.76%
• 1 month: 22.96%
• 3 months: 22.91%
• 6 months: 52.33%
• Year to date: 27.71%
• 1 year: 379.06%
• 5 years: -69.27%
• 10 years: -99.39%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. It focuses on improving cancer diagnostics, particularly hematologic malignancies. Its objective is to enhance diagnostic accuracy and accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, and Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division and the Products Division.

Employees: 71